LLY — ELI LILLY & Co
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 59478 ·
Last close
$1183.46
Market Cap
$1.06T
52W High
$1292.65
52W Low
$711.59
ADV30
2,422,043
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 22,974,000,000 | 19,706,000,000 | 12,457,000,000 | 7,095,000,000 | 142,283,000,000 | 8,950,000,000 | 108,404,000,000 |
| Mar 2026 | 19,799,000,000 | 16,222,000,000 | 9,778,000,000 | 7,396,000,000 | 116,576,000,000 | 5,282,000,000 | 85,378,000,000 |
| Dec 2025 | 19,292,000,000 | 15,920,300,000 | 8,987,400,000 | 6,637,700,000 | 112,476,000,000 | 7,268,000,000 | 85,941,000,000 |
| Sep 2025 | 17,600,800,000 | 14,592,500,000 | 8,386,100,000 | 5,582,500,000 | 114,935,400,000 | 9,791,900,000 | 91,084,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$20,480,000,000
Investing CF
$-11,535,000,000
Financing CF
$-7,063,000,000
CapEx
$-10,112,000,000
Dividends Paid
$-5,586,000,000
Buybacks
$-5,264,000,000
EPS Diluted TTM
$28.15
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$29,514,000,000
Inventory
$14,529,000,000
Receivables
$21,177,000,000
ST Investments
$121,600,000
EBIT TTM
$35,774,200,000
Pretax Income TTM
$31,125,000,000
Interest Exp TTM
$897,000,000
Analysts
27
Yahoo Snapshot (yfinance, live)
Total Revenue
$79,666,003,968
EBITDA
$41,706,999,808
Free Cash Flow
$11,065,900,032
Enterprise Value
$1,040,445,079,552
Total Cash
$8,949,999,616
Total Debt
$54,907,998,208
Shares Out
891,741,406
Trailing EPS
$29.79
Book Value
$38.00
ROE
102.3%
ROA
20.4%
Div Yield
0.62%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 65,179,000,000 | 29,696,000,000 | 20,640,000,000 | 112,476,000,000 | 85,941,000,000 | 26,535,000,000 | 16,813,000,000 |
| Dec 2024 | 45,043,000,000 | 17,040,000,000 | 10,590,000,000 | 78,715,000,000 | 64,443,000,000 | 14,272,000,000 | 8,818,000,000 |
| Dec 2023 | 34,124,000,000 | 10,325,000,000 | 5,240,000,000 | 64,006,300,000 | 53,142,600,000 | 10,771,900,000 | 4,240,000,000 |
| Dec 2022 | 28,541,400,000 | 8,280,400,000 | 6,244,800,000 | 49,489,800,000 | 38,714,400,000 | 10,649,800,000 | 7,585,700,000 |
TTM Snapshot
Revenues TTM
$40,608,300,000
NetIncome TTM
$5,123,600,000
OpCashFlow TTM
$0
Assets (Latest)
$112,476,000,000
Forward EPS
$47.24
Max Pain — expiry 2026-10-02
max pain strike: $1160.00 · spot: $1189.95 · call oi: 12,658 · put oi: 14,520
Expected Move to 2026-10-02:
±$37.75
(3.17%) —
implied range
$1152.20 –
$1227.70
· ATM straddle on $1190.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | $653.61B | $271.22 | — |
| ABBV | AbbVie Inc. | $467.12B | $264.34 | — |
| MRK | Merck & Co., Inc. | $367.07B | $148.78 | — |
| NVS | NOVARTIS AG | $276.48B | $145.46 | — |
| AZN | ASTRAZENECA PLC | $258.35B | $166.58 | — |
News headlines (Yahoo Finance, 1h cache)
He Will Switch Contractors to Help Build Eli Lilly’s $6.5 Billion Plant. Two W-2s Could Put $2,821 in Social Security Taxes Back in His Pocket
2026-09-28 14:32 · Yahoo
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?
2026-09-28 13:21 · Yahoo
Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come
2026-09-28 12:12 · Yahoo
Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICs
2026-09-28 10:45 · Yahoo
Eli Lilly Just Announced Game-Changing News
2026-09-28 08:23 · Yahoo
Eli Lilly Wins FDA Approval for Weekly Insulin. Here’s What Comes Next
2026-09-28 06:32 · Yahoo
Eli Lilly and Company (LLY) is Expanding Beyond its Biggest Growth Drivers. Can it Sustain the Momentum?
2026-09-28 04:11 · Yahoo
Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch
2026-09-28 03:31 · Yahoo
A New Wave of Senior Patients Could Extend Lilly’s GLP-1 Growth Story
2026-09-27 20:26 · Yahoo
Lilly’s Oral GLP-1 Push Gains Momentum. Can Foundayo Become its Next Growth Engine?
2026-09-27 20:24 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.